Pharmac's new Chief Medical Officer shares updated advisory committee terms of reference

on 21 October

Kia ora koutou,

I’m very pleased to introduce myself as the new Chief Medical Officer at Pharmac.

I also wanted to take the opportunity to let you know that we have new terms of reference for our advisory committees that will come into effect from 1 November.

You can find full details of the updated terms of reference on the Pharmac website but the major changes are:

  1. Broadening the role of Pharmac’s Consumer Advisory Committee to allow them to be involved in all areas of our work, including the potential for medicine funding proposals
  2. Renaming Subcommittees of PTAC as Specialist Advisory Committees with their own terms of reference
  3. Increasing consumer input into our clinical advisory committees, including the potential to have a consumer member on PTAC and on our Specialist Advisory Committees     
  4. Enhancing health equity expertise and diversity on our clinical advisory committees
  5. Removing much of the administrative detail, such as meeting management and recruitment processes, from the terms of reference to shift to a Member Handbook.

Some of these changes will take a bit of time to implement so it won’t all happen immediately. We are working internally and with our advisors over the coming months to implement the changes.

Please get in touch with any questions or feedback you might have for me about Pharmac and the advisory committees. We’re always keen to hear from you and I’m looking forward to engaging with you over the coming months

Ngā mihi,



David Hughes | Chief Medical Officer (he/him)
PHARMAC | Te Pātaka Whaioranga | PO Box 10 254 | Level 9, 40 Mercer Street, Wellington

Back to blog entries

Areas of Interest